RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
75A50126R00002 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) solicitation, performed in Washington, DC, with responses due 2026-07-30. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Comparable recent awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| HJ SCIENCE & TECHNOLOGY INC | $167K | 7 | 2024-09-30 |
| NOU SYSTEMS INC | $167K | 7 | 2024-09-30 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES | $4.3M | 1 | 2024-09-30 |
| IXI TECHNOLOGY INC | $167K | 7 | 2024-09-30 |
| APPLIED RESEARCH ASSOCIATES, INC. | $2.5M | 1 | 2024-09-30 |
Explore the market
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.